
Medtronic plc
MDTNYSEHealthcareMedical - Devices
Latest quote
$93.36
+$1.05 · +1.14%
MDT company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
84
Deep Value
Momentum
43
Neutral
Sentiment
65
Bullish
Risk resilience
70
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteMedtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- IE
- CEO
- Geoffrey Straub Martha
- Listed since
- May 2, 1973
- Employees
- 95,000
Market position
- Volume
- 7.49M
- 0.81× average
- Average volume
- 9.3M
- Average daily volume
- Market cap
- 119.49B USD
- Beta
- 0.57
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 132.81B USD
- P/E (TTM)
- 24.89×
- P/B (TTM)
- 2.42×
- P/S (TTM)
- 3.29×
- EV / EBITDA
- 13.54×
- Earnings yield
- 4.49%
- Free cash flow yield
- 5.08%
- Dividend yield
- 3.05%
Profitability & efficiency
- Gross margin
- 65.02%
- Operating margin
- 17.78%
- Net margin
- 13.20%
- Return on equity
- 9.70%
- Return on assets
- 5.16%
- Return on invested capital
- 6.13%
Financial health
- Debt / equity
- 0.57×
- Current ratio
- 2.13×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 36.36B USD | 33.54B USD | 32.36B USD | 31.23B USD | 31.69B USD |
| Cost of goods sold | 12.72B USD | 11.63B USD | 11.22B USD | 10.72B USD | 10.15B USD |
| Gross profit | 23.64B USD | 21.91B USD | 21.15B USD | 20.51B USD | 21.54B USD |
| Research and development | 2.87B USD | 2.73B USD | 2.74B USD | 2.7B USD | 2.75B USD |
| Selling, general, and administrative | 11.78B USD | 10.85B USD | 10.74B USD | 10.42B USD | 10.29B USD |
| Operating expenses | 17.18B USD | 15.95B USD | 16B USD | 15.02B USD | 15.79B USD |
| Interest expense | 715M USD | 729M USD | 719M USD | 636M USD | 553M USD |
| Depreciation and amortization | 2.96B USD | 2.86B USD | 2.65B USD | 2.7B USD | 2.71B USD |
| Operating income | 6.47B USD | 5.96B USD | 5.14B USD | 5.49B USD | 5.75B USD |
| Net income | 4.8B USD | 4.66B USD | 3.68B USD | 3.76B USD | 5.04B USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 100%
- 11 beats, 0 misses, 0 met estimates
- Average EPS surprise
- +2.38%
- 11 comparable reports
- Latest EPS result
- 1.55
- Estimate 1.54 · Beat by 0.65%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
51 ratingsMDT news
MDT peers
ETFs holding MDT
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI3.49B0.15%2.3T USD0.03%$378.24+0.44%
Vanguard S&P 500 ETFVOO2.88B0.17%1.7T USD0.03%$703.71+0.39%
State Street SPDR S&P 500 ETFSPY1.47B0.18%817.87B USD0.09%$765.72+0.41%
Vanguard Morningstar Value ETFVTV1.04B0.41%256.5B USD0.03%$226.4+0.54%
State Street Health Care Select Sector SPDR ETFXLV852.42M1.90%44.76B USD0.08%$174.62+1.29%
Vanguard Dividend Appreciation ETFVIG620.29M0.47%130.9B USD0.04%$243.91+0.69%
Vanguard High Dividend Yield ETFVYM441.05M0.44%99.2B USD0.04%$164.97+0.59%
State Street SPDR S&P Dividend ETFSDY389.02M1.76%22.07B USD0.35%$158.44+0.23%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 3.49B
- Weight
- 0.15%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard S&P 500 ETFVOO- Market value
- 2.88B
- Weight
- 0.17%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.71+0.39%
State Street SPDR S&P 500 ETFSPY- Market value
- 1.47B
- Weight
- 0.18%
- AUM
- 817.87B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.72+0.41%
Vanguard Morningstar Value ETFVTV- Market value
- 1.04B
- Weight
- 0.41%
- AUM
- 256.5B USD
- Expense ratio
- 0.03%
- Price / 1D
- $226.4+0.54%
State Street Health Care Select Sector SPDR ETFXLV- Market value
- 852.42M
- Weight
- 1.90%
- AUM
- 44.76B USD
- Expense ratio
- 0.08%
- Price / 1D
- $174.62+1.29%
Vanguard Dividend Appreciation ETFVIG- Market value
- 620.29M
- Weight
- 0.47%
- AUM
- 130.9B USD
- Expense ratio
- 0.04%
- Price / 1D
- $243.91+0.69%
Vanguard High Dividend Yield ETFVYM- Market value
- 441.05M
- Weight
- 0.44%
- AUM
- 99.2B USD
- Expense ratio
- 0.04%
- Price / 1D
- $164.97+0.59%
State Street SPDR S&P Dividend ETFSDY- Market value
- 389.02M
- Weight
- 1.76%
- AUM
- 22.07B USD
- Expense ratio
- 0.35%
- Price / 1D
- $158.44+0.23%
Continue in GoAI
Research MDTresearch.disclaimer











